baber/WOPTO huggingface dataset:
Patent AU-613943-B2 (AU)
Title: Moisture presence alarm system
Inventor: DARLING JOHN EDWARD
IPC: G01M/
Filed: 1988-07-21
Granted: 1991-08-15
Abstract: A moisture presence alarm system has a sensor system which extends over an area to be monitored and a detector device which receives signals from the sensor system. This has spatially separated conductors in conductive contact with a moisture absorbent material. The position of the leak is determined by selective interrogation of pairs of conductors. The conductors may be in an orthogonal matrix (A1...X1; A2...X2), each conductor (10, 11) being associated with a moisture absorbent strip (12, 13).
Patent AU-608640-B2 (AU)
Title: Improved process for making superconductors
Inventor: HOROWITZ HAROLD SAUL
IPC: C01F1/00
Filed: 1988-06-08
Granted: 1991-04-11
Abstract: There is disclosed an improved process for preparing a superconducting composition having the formula MwAzCuvOx wherein M is selected from the group consisting if Bi, Tl, Y, Nd, Sm, Eu, Gd, Dy, Ho, Er, Tm Yb and Lu; A is at least one alkaline earth metal selected from the group consisting of Ba, Ca and Sr; x is at least 6; w is at least 1; z is at least 2 and v is at least 1; said composition having a superconducting transition temperature of above 77 K, preferably above about 90 K; said process consisting essentially of (a) forming a suspension having an M:A:Cu atomic ratio of w:z:v by mixing A(OH)2, AO or AO2and M2O3 with an aqueous solution of cupric carboxylate or cupric nitrate at a temperature from about 50 DEG  C. to about 100 DEG  C., or mixing A(OH)2 with an aqueous solution of Cu carboxylate, nitrate or a mixture thereof and M carboxylate, nitrate or a mixture thereof at a temperature from about 50 DEG  C. to about 100 DEG  C.; (b) drying the suspension formed in step (a) to obtain a precursor powder; and (c) heating and cooling the powder under specified conditions to form the desired superconducting composition. Shaped articles thereof are also disclosed.
Patent AU-743145-B2 (AU)
Title: A prosthesis structure
Inventor: JACOBSSON MAGNUS
IPC: A61B17/56
Filed: 1999-12-21
Granted: 2002-01-17
Abstract: The invention provides a prosthesis structure for anchorage to the joint end of an articulatory part of a joint in a human or animal body which comprises an engagement element which presents a flat or a substantially flat engagement surface for engaging with a complementary joint end surface provided at the joint end and an elongate fixture connected to and spaced from the engagement surface for insertion into a complementary bore provided at the joint end at a distance from the joint end surface. The invention further provides that the elongate fixture forms an acute angle with the engagement surface.
Patent AU-685662-B2 (AU)
Title: Tapered culinary dispensing device
Inventor: LEE IDA JESSICA SAU MING
IPC: A21C15/00
Filed: 1995-07-28
Granted: 1998-01-22
Abstract: PCT No. PCT/GB95/01775 Sec. 371 Date Mar. 27, 1996 Sec. 102(e) Date Mar. 27, 1996 PCT Filed Jul. 28, 1995 PCT Pub. No. WO96/03884 PCT Pub. Date Feb. 15, 1996A dispensing device for dispensing cake toppings or the like, comprising a frusto-conical container having an outlet formed in the base thereof and a valve assembly for closing the outlet. The valve assembly comprises two downwardly-inclined shutters hinged to opposite sidewalls of the outlet, the shutters being pivotally connected to respective branches of a bifurcated actuating member. A trigger is provided on the inner surface of a handle, for actuating the valve assembly. A sieve member may also be provided. In use, the container is filled with the topping material to be dispensed. The user holds the device over, for example, a cake and actuates the valve assembly to dispense the material, thereby ensuring that all of the material is dispensed onto the desired area of the cake.
Patent AU-580974-B2 (AU)
Title: Catalyst and process for polymerising olefins
Inventor: COLLOMB-CECCARINI JOELLE
IPC: C08F10/00
Filed: 1984-11-21
Granted: 1989-02-09
Abstract: The invention relates to a process for preparing supported catalysts for the copolymerization of ethylene with higher alpha-olefins, characterized in that a compound of a transition metal of Groups IV, V and VI of the Periodic Table of Elements, used at its maximum valency, is precipitated on to a support of magnesium chloride and possibly aluminum chloride by a reduction reaction in two stages, employing reducing agents selected for the first stage from among alkylaluminum dihalides, and for the second stage from among organo-metallic compounds with a higher reducing power than that of the alkylaluminum dihalides. These catalysts are particularly well suited to the copolymerization in the gas phase of ethylene and higher alpha-olefins.
Patent AU-579138-B2 (AU)
Title: Flame retardant insulating compound
Inventor: KLETT THOMAS ANDREAS
IPC: C08K3/22
Filed: 1985-02-25
Granted: 1988-11-17
Abstract: The flame-retardant insulating mixture for sheathing electrical cables and lines comprises from 40 to 100 parts by weight of a copolymer of ethylene with acrylic acid and/or an acrylate, with an ethylene content of from 70 to 95 % by weight, and from 100 to 170 parts by weight of aluminium hydroxide. The acrylate employed is preferably butyl acrylate. Said mixtures need not be crosslinked and have particularly low values for the tear propagation strength, so that they are particularly suitable for jointing processes in which automatic insulation takes place.
Patent AU-578935-B2 (AU)
Title: Process for preparing 2-hydrazino-1,3-diazacycloalk-2-ene hydrohalides
Inventor: PADMANATHAN THURAIRAJAH
IPC: C07D245/02
Filed: 1985-03-07
Granted: 1988-11-10
Abstract: This invention provides a process for preparing a 2-hydrazino-1,3-diazacycloalk-2-ene hydrohalide The process comprises reacting a one molar proportion of either tautomeric isomer of a 2-nitroamino-1,3-diazacycloalk-2-ene represented by the following formulas:wherein R<sup>1</sup> is hydrogen, C<sub>1</sub>-C<sub>6</sub> alkyl, C,- C<sub>6</sub> hydroxyalkyl, C,-C<sub>6</sub> alkoxyalkyl, phenyl, substituted phenyl, benzyl, or substituted benzyl, R<sup>2</sup> and R<sup>3</sup> are independently hydrogen, C,- C<sub>6</sub> alkyl, C<sub>1</sub>-C<sub>6</sub> alkoxy, C,-C<sub>s</sub> alkoxyalkyl, hydroxyl, aryl, substituted aryl, aralkyl and substituted aralkyl, and n is an integer from 0 to 3 with about an equimolar proportion of an ammonium halide or hydrazonium halide, and about a 1 to 2 molar proportion of hydrazine hydrate in a composition selected from a C, to C, aliphatic alcohol, water or a mixture thereof, at a temperature from about ambient to the reflux, and isolating the end product as a monohydrohalide.This invention also provides a process for preparing a 2- hydrazino 1. 3-diazacycloalk-2-ene dihydrohalide. The process comprises reacting a compound of the formula:wherein R<sup>1</sup> is hydrogen, C, to C<sub>6</sub> alkyl, or C, to C<sub>6</sub> hydroxyalkyl, R<sup>2</sup> and R<sup>3</sup> are independently hydrogen or C, to C<sub>6</sub> alkyl, n is 0 to 3 and X is a halide ion, with hydrogen halide wherein the halide ion is the same as defined above in a C, to C<sub>4</sub> alkyl alcohol at about 0 to 30C.; and recovering the corresponding 2-hydrazino-1, 3-diazacycloalk-2-ene dihydrohalide.
Patent AU-683784-B2 (AU)
Title: Continuously variable hydrostatic transmission including a pulse width modulation ratio controller
Inventor: LARKIN ROBERT FRANCIS
IPC: F15B11/08
Filed: 1995-10-31
Granted: 1997-11-20
Abstract: A controller for changing the ratio of a continuously variable hydrostatic transmission, as determined by the angular position of a swashplate, including an actuator having a cylinder slidingly receiving a piston to define a pair of chambers. A pair of solenoid valves, each configured to connect a respective chamber selectively to sump pump pressure or atmospheric pressure, are energized with a stream of pulses to create differential fluid pressures in the chambers, thereby producing movement of the piston; the piston movement being linked to the swashplate to produce a corresponding adjustment of the swashplate angular position. The rate of change of the swashplate angular position is controlled by pulse width modulating the pulse stream.
Patent AU-661591-B2 (AU)
Title: 5,10-methylenetetrahydrofolic acid-cyclodextrin inclusion compounds
Inventor: MULLER HANS RUDOLF
IPC: A61K47/48
Filed: 1993-07-09
Granted: 1995-07-27
Abstract: The invention relates to cyclodextrin inclusion compounds of 5,10-methylenetetrahydrofolic acid. The surprisingly high stability of these compounds makes it possible to use them pharmaceutically for the first time. The invention also relates to a process for preparing the said substances and to their use for producing pharmaceutical compositions.
Patent AU-751160-B2 (AU)
Title: Terminal block for a protective relay
Inventor: DIAS CLIVE
IPC: H01H45/14
Filed: 1999-06-04
Granted: 2002-08-08
Abstract: A modular terminal block for connection between an electrical distribution system and the processing circuitry of a protective relay. The terminal block includes multiple separable tiers, each which is provided with a set of terminal connections and signal contacts. The tiers are of different lengths such that each set of terminal connections are located at different distances from the protective relay to improve accessibility. The terminal block can be mounted in different orientations, and allow shorting between any two adjacent terminal connections.
Patent AU-571986-B2 (AU)
Title: 17,21-diacylates of 9-alpha-fluoro or chloro 17,21 -dihydroxy-corticosteroids
Inventor: VILLAX JOAO EMRICA
IPC: C07J5/00
Filed: 1985-07-24
Granted: 1988-04-28
Abstract: Novel esters of 9a-fluoro- and chloro-corticosteroids of the formulawherein Y is chlorine or OR<sub>1</sub>, R<sub>1</sub> and R<sub>2</sub> represent an acyl group of 2-6 carbon atoms or a benzoyl group and where R<sub>1</sub> and R<sub>2</sub> can be the same or different in the same molecule, R<sub>3</sub> is methyl or fluorine in either the α- or β- orientation, X is chlorine or fluorine, and the bond can be saturated or not, especially those compounds of the formulawherein Y and R<sub>2</sub> have the significance given above, are prepared by reacting the respective 9β, 11β-epoxy compounds with hydrogen fluoride or chloride.
Patent AU-714619-B2 (AU)
Title: Seal and process for producing such seal
Inventor: GRABE WERNER
IPC: E21D11/38
Filed: 1996-03-01
Granted: 2000-01-06
Abstract: PCT No. PCT/FR96/00326 Sec. 371 Date Feb. 20, 1998 Sec. 102(e) Date Feb. 20, 1998 PCT Filed Mar. 1, 1996 PCT Pub. No. WO96/27073 PCT Pub. Date Sep. 6, 1996The invention relates to a seal between a side face of a first part (11) and an application face (10), the seal being made of a compressible profiled lining (1) and being comprised of an internal portion (2) sealingly fixed to the first part (11) and an external portion (3) bearing on the application face (10). According to the invention, in its original condition prior to setting the seal on the first part (11), the external portion (3) of the liner (1) is provided with at least one profile tongue (4) housed inside at least one longitudinal groove (5) provided in said external portion (3) and opening on the side of the application face (10), said tongue (4) being fixed to the internal face (50) of said groove (5) in an easily detachable way so as to be able to suppress and eventually replace the tongue (4) at least on a portion of the length of the liner (1) in order to vary the compressibility degree of the liner on the corresponding length. The invention applies particularly to seals between the side faces of prefabricated concrete voussoirs for the construction of tunnels.
Patent AU-716496-B2 (AU)
Title: Assay using marked microbial host cell strains
Inventor: MCFARLAND NANCY C
IPC: C12N1/21
Filed: 1997-10-10
Granted: 2000-02-24
Abstract: Presence of a contaminating microbial host cell (A), in a culture vessel containing a different host cell (B) able to use more than one carbohydrate (I), is detected by: (a) culturing (B), which includes nucleic acid encoding a particular polypeptide (II) and genetically marked so that it can not use a selected (I), (Ia), as substrate; (b) plating an isolated sample of the culture on a medium supplemented by (Ia); (c) incubating the plated cells, and (d) detecting if any colonies grow in the (Ia)-containing medium. Optionally (A) that grow in the supplemented medium may be plated on a field of different (I) to identify them from their specific (I)-utilising characteristics. The cells are yeasts or prokaryotes, particularly Gram-negative bacteria and specifically E. coli. They express an exogenous (II) and utilise e.g. maltose, ribose or rhamnose. (B) is genetically marked by making (a) a non-reversing, non-suppressing alteration in its genotype, in which case the sample is not diluted before plating or (b) a genotypic alteration that results in a carbohydrate utilisation revertant or suppressant, in which case the sample is serially diluted before plating. Optionally the strain is doubly marked by altering two (I)-utilisation pathways; (i) one type (a), in ribose utilisation and the other a reverting or suppressing mutation in rhamnose utilisation or (ii) both type (a), in maltose and ribose utilisation. Where two alterations are present, two plates are used in step (b), each supplemented with different (I). The vessel is a fermentor containing, before dilution, 108-1011 colony-forming units (cfu)/ml.
Patent AU-627850-B2 (AU)
Title: Bone collagen matrix for implants
Inventor: KUBERASAMPATH THANGAVEL
IPC: A61L27/24
Filed: 1990-02-22
Granted: 1992-09-03
Abstract: A matrix for implantation in a mammalian host comprising biocompatible, mineral-free, insoluble Type-I bone collagen which may be allogenic or xenogenic to the host, and which, when implanted in the host, is biodegradable. The collagen is treated with a collagen fibril modifying substance such as acidified acetonitrile, chloroform, or dichloromethane, or by heating in an aqueous environment to a temperature of 37 DEG -65 DEG  C. The treated material undergoes a change in morphology involving a significant increase in its surface area as measured by various methods. Under the scanning electron microscope the material has an "oyster shell" appearance with many pits and micropores.
Patent AU-665655-B2 (AU)
Title: Dual connections
Inventor: FERGUSON STEPHEN PATRICK
IPC: H04L69/40
Filed: 1993-11-30
Granted: 1996-01-11
Abstract: Data is protected in a data transmission system operating on the synchronous digital hierarchy. The data is transmitted in multiplex form between ports in the system and protection is applied between ports at different or the same aggregate bit rates. This protection is achieved by selecting between individual portions of the payload within the aggregate signals and each part of mutually protective portions has the same nominal traffic capacity. By duplexing an alternative signal path is created to ensure a continuity of traffic through the system in the event of a fault in one path. <IMAGE>
Patent AU-561326-B2 (AU)
Title: Specific determination of pancreatic alpha amylase
Inventor: LENZ HELMUT
IPC: C12Q1/40
Filed: 1986-07-18
Granted: 1987-05-07
Abstract: 1. Process for the specific determination of pancreatic alpha-amylase in body fluids, especially in serum, plasma, duodenal juice or urine, by reaction with a system for the detection of alpha-amylase in the presence of a monoclonal antibody which inhibits salivary alpha-amylase, characterised in that, as inhibitor, there is used a first monoclonal antibody which specifically inhibits the salivary enzyme by more than 70% but less than 97%, in combination with a second monoclonal anti-salivary alpha-amylase antibody which inhibits this enzyme by less than 10%.
Patent AU-668290-B2 (AU)
Title: A pharmaceutical composition for topical administration of antigens and/or vaccines to mammals via a mucosal membrane
Inventor: GIZURARSON SVEINBJORN
IPC: A61K9/00
Filed: 1994-02-14
Granted: 1996-04-26
Abstract: PCT No. PCT/DK94/00062 Sec. 371 Date Oct. 6, 1995 Sec. 102(e) Date Oct. 6, 1995 PCT Filed Feb. 14, 1994 PCT Pub. No. WO94/17827 PCT Pub. Date Aug. 18, 1994A novel type of formulation for the topical administration of antigens and/or vaccines to mammals via mucosal membranes comprising one or more adjuvants/vehicles selected from (a) polyoxyethylene sorbitan monoesters, (b) polyoxyethylene castor oil, (c) caprylic/capric acid glycerides and (d) gangliosides in an amount of 0.01 to 15% (v/v) calculated on the total volume of the preparation. This formulation enhances the immunological response n a mammal following mucosal administration, e.g. nasal, oral, rectal or vaginal application.
Patent AU-640702-B2 (AU)
Title: Method for removing amine from solids
IPC: C09K23/04
Filed: 1990-10-29
Granted: 1993-09-02
Abstract: A method for reducing the residual amine content of dried solids by adding water to the dried solids to form a wetted solids mixture and drying the wetted solids mixture to yield a dried product with a final amine content less than the residual amine content of the dried solids. An alkaline composition is also disclosed which further reduces the final amine content of the dried product.
Patent AU-701015-B2 (AU)
Title: Vibratory conveyor system for adjusting the periodic resultant forces supplied to a conveyor trough
Inventor: SCHIEBER DOUGLAS A
IPC: B65G27/20
Filed: 1996-07-25
Granted: 1999-01-21
Abstract: A vibratory system for changing or maintaining a resultant vibratory force supplied to a spring support conveyor trough has a pair of spaced, parallel shafts and phase elements for supplying a resultant to force to the trough. A sensing device generates a signal corresponding to the real time phase angle between the phase elements. This signal is compared to a signal corresponding to the desired phase angle and the real time phase angle is essentially the same as the desired phase angle thereby providing the desired resultant force to the conveyor.
Patent AU-555444-B2 (AU)
Title: Cephalosporin derivatives
Inventor: BLUMBACH JURGEN
IPC: C07D501/46
Filed: 1981-02-20
Granted: 1986-09-25
Abstract: What are disclosed are cephalosporin compounds of the formula <IMAGE>  1  pharmaceutical preparations which are active against bacterial infections and in which these cephem compounds are present, process for the preparation of the cephem compounds and of the pharmaceutical preparations, use of the cephem compounds for combating bacterial infections, and compounds used as starting materials in the synthesis of said cephem compounds.
Patent AU-634003-B2 (AU)
Title: 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
IPC: C07D249/12
Filed: 1990-12-14
Granted: 1993-02-11
Abstract: This invention relates to 4-benzyl-5-phenyl-1,2,4-dihydro-3H-1,2,4-triazol-3-ones and to their use as anticonvulsants for treatment of seizure disorders.
Patent AU-635618-B2 (AU)
Title: Fluid injection system pump and pumping methods
IPC: A61L2/24
Filed: 1991-03-04
Granted: 1993-03-25
Abstract: A cassette (18) containing a group of sealed cells is used as a means for delivering doses of fluid to be injected into a sterilizing chamber (10). After the cassette (18) is automatically positioned over a piercing mechanism, the cassette (18) is moved downwardly so that a cell is pierced. Fluid is then forced out of the cell by pneumatic pressure into an injector valve (22), which opens in a manner which does not adversely affect a vacuum within the chamber (10).
Patent AU-551630-B2 (AU)
Title: Liquid containing sachet
Inventor: GRAY ROY FRED
IPC: B65D75/36
Filed: 1981-08-06
Granted: 1986-05-08
Abstract: A sachet which comprises a sealed bag containing a compressible and porous carrier which is held under compression within the sachet by pressure exerted by the walls of the sachet onto the carrier, the carrier being thoroughly impregnated with liquid suitably an antiseptic. Methods are provided for manufacture of the sachets. The carriers in such sachets containing antiseptic liquid have reduced tendency to harbor bacteria, and are preferably open or reticulated cell foam sponges.
Patent AU-611088-B2 (AU)
Title: Human erythropoietin gene: high level expression in stably transfected mammalian cells
Inventor: POWELL JERRY S
IPC: C12N15/85
Filed: 1987-06-26
Granted: 1991-06-06
Abstract: The Apa I restriction fragment of the human erythropoietin gene, for producing high titers of biologically active hormone from stably transfected cell lines.
Patent AU-543478-B2 (AU)
Title: Superfatted liquid soap skin cleaning composition
Inventor: STIROS PAUL
IPC: A61K8/36
Filed: 1981-09-01
Granted: 1985-04-18
Abstract: Clear, aqueous liquid skin cleansing compositions comprising saturated and unsaturated potassium soaps and free fatty acid.
Patent AU-737862-B2 (AU)
Title: Methods and compositions to identify swine genetically resistant to F18 E. Coli associated diseases
Inventor: BOSWORTH BRAD T
IPC: C12Q1/6876
Filed: 1998-05-20
Granted: 2001-08-30
Abstract: The present invention provides non-invasive methods and compositions to differentiate, with a high level of sensitivity and specificity, swine that are genetically susceptible to diseases associated with F18 E. coli infection, from resistant swine. DNA polymorphisms in the swine alpha (1,2) fucosyltransferase 1 (FUT1) gene were used to differentiate resistant from susceptible swine. The invention includes a polypeptide with amino acid substitutions, encoded by the nucleotide polymorphisms, a molecular diagnostic assay, and a kit for the differentiation, of E. coli F18-adhesion resistant, heterozygous (carrier) and homozygous susceptible pigs. The molecular test identifies susceptibility to oedema disease and postweaning diarrhea with high sensitivity and specificity, therefore, is useful to swine breeder in their effort to enhance for resistance. Information on the polymorphisms of the present invention provides insight into causation and treatment of E. coli associated intestinal disorders.
Patent AU-682893-B2 (AU)
Title: Peptides that elicit neutralizing antibodies against genetically divergent HIV-1 strains
Inventor: KATINGER HERMANN
IPC: C07K4/00
Filed: 1994-09-12
Granted: 1997-10-23
Abstract: Peptides are described which elicit antibodies, preferably including secretory antibodies secreted by mucosal surfaces, that show neutralizing activity against different strains and clinical isolates of HIV-1 and that inhibit the fusion of cells caused by HIV-1, which peptides are composed of a sequence of seven or eight amino acids corresponding to the ones on gp41 of gp160 of the HIV isolate BH10 at the position 662 to 668 (ELDKWAS) or at the position 661 to 668 (LELDKWAS) respectively, preferably including peptides being composed of the sequence ELDNWAS, ELNKWAS, LELDNWAS or LELNKWAS, or that are genetically encoded by nucleotide sequences corresponding to said amino acid sequences, or by sequences hybridizing to said nucleotide sequences, or by sequences deduced from said nucleotide sequences by degeneration. Preferably, the peptides substitute one or more parts of the amino acid sequence of a viral protein or are inserted into antigenic sites of a viral protein, e.g. by fusion of the respective nucleotide sequences, and subsequent expression of the fusion genes is carried out in a biological expression system.
Patent AU-773087-B2 (AU)
Title: Assay device
Inventor: CRISANTI ANDREA
IPC: G01N33/558
Filed: 2000-10-13
Granted: 2004-05-13
Abstract: The invention provides an assay device for quantification or detection of the presence or absence of an analyte in a liquid sample, comprising a molding (1) permanently or removably attached to a substantially planar plate (2) such that a part of said molding forms a capillary chamber (3) between said plate and the said molding, the device further comprising a chamber (5) into which a test sample and/or reagent can be introduced and further comprising a chamber (7) capable of accommodating an absorbent pad, wherein the said chamber into which a test sample and said chamber capable of holding an absorbent pad are in lateral flow contact via the said capillary chamber (3).